Fig. 3
From: The role of proteoglycan form of DMP1 in cranial repair
Alterations in osteogenic and PG markers in the injury sites of the WT and S89G-DMP1 mice. (A1-D3) The S89G-DMP1 mice exhibited decreased immunoreactivity of RUNX2 and ALP in the cranial defect sites. Scale bars = 100 µm. E RT‒qPCR analysis of osteogenic and PG-related markers. *p < 0.05, n = 4